Physician profile
Nima Kokabi
NPI 1932495298
$1,048,527.78
in general payments reported to CMS, 2019-2025
14 companies · $464K in 2025
The $464K reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $9,460 · 2021: $10K · 2022: $57K · 2023: $145K · 2024: $362K · 2025: $464K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $574K · Consulting Fee: $307K · Travel and Lodging: $74K · Food and Beverage: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $574,010.00 |
| Consulting Fee | $307,399.00 |
| Travel and Lodging | $74,197.18 |
| Food and Beverage | $16,085.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $676,262.47 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Okami Medical, INC. | $206,709.10 | 2023-2025 | Lobo |
| Trisalus Life Sciences, INC. | $73,600.00 | 2025 | Trinav Infusion System |
| Boston Scientific Corporation | $56,228.46 | 2021-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Administration Set, Embold Fibered |
| Siemens Medical Solutions USA, INC. | $9,008.24 | 2022-2024 | |
| Balt USA, LLC | $8,507.46 | 2022 | |
| Terumo Medical Corporation | $7,377.84 | 2023-2025 | Azur Cx Detachable, Navicross, Glidewire |
| Galvanize Therapeutics, INC | $7,200.00 | 2025 | Aliya System |
| Becton, Dickinson and Company | $1,785.00 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,278.48 | 2024-2025 | Imfinzi |
| Medtronic, INC. | $336.51 | 2022-2025 | Concertotm, Abre |
| Ethicon US, LLC | $150.98 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $56.49 | 2020 | |
| Medtronic Vascular, INC. | $26.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nima Kokabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.